Literature DB >> 24623199

Diabetes mellitus and dementia.

Toshiharu Ninomiya1.   

Abstract

Growing epidemiologic evidence has suggested that people with diabetes mellitus are at an increased risk for the development of dementia. However, the results for the subtypes of dementia are inconsistent. This review examines the risk of dementia in people with diabetes mellitus, and discusses the possible mechanism underpinning this association. Diabetes mellitus is associated with a 1.5- to 2.5-fold greater risk of dementia among community-dwelling elderly people. Notably, diabetes mellitus is a significant risk factor for not only vascular dementia, but also Alzheimer's disease. The mechanisms underpinning the association are unclear, but it may be multifactorial in nature, involving factors such as cardiovascular risk factors, glucose toxicity, changes in insulin metabolism and inflammation. The optimal management of these risk factors in early life may be important to prevent late-life dementia. Furthermore, novel therapeutic strategies will be needed to prevent or reduce the development of dementia in people with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24623199     DOI: 10.1007/s11892-014-0487-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  70 in total

Review 1.  Synaptic plasticity in the diabetic brain: advanced aging?

Authors:  A Artola; A Kamal; G M J Ramakers; F Gardoni; M Di Luca; G J Biessels; F Cattabeni; W H Gispen
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

2.  Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

Authors:  A Convit; M J De Leon; C Tarshish; S De Santi; W Tsui; H Rusinek; A George
Journal:  Neurobiol Aging       Date:  1997 Mar-Apr       Impact factor: 4.673

Review 3.  Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

Authors:  Joseph Rogers; Diego Mastroeni; Brian Leonard; Jeffrey Joyce; Andrew Grover
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

4.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

5.  C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.

Authors:  R Nesto
Journal:  Diabet Med       Date:  2004-08       Impact factor: 4.359

6.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

Review 7.  Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

Authors:  Bernadette McGuinness; Stephen Todd; Peter Passmore; Roger Bullock
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

8.  Inflammation and rate of cognitive change in high-functioning older adults.

Authors:  Dawn E Alley; Eileen M Crimmins; Arun Karlamangla; Peifeng Hu; Teresa E Seeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-01       Impact factor: 6.053

9.  Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Riccardo E Marioni; Mark W J Strachan; Rebecca M Reynolds; Gordon D O Lowe; Rory J Mitchell; F Gerry R Fowkes; Brian M Frier; Amanda J Lee; Isabella Butcher; Ann Rumley; Gordon D Murray; Ian J Deary; Jackie F Price
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

10.  Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.

Authors:  Christelle Raffaitin; Henri Gin; Jean-Philippe Empana; Catherine Helmer; Claudine Berr; Christophe Tzourio; Florence Portet; Jean-François Dartigues; Annick Alpérovitch; Pascale Barberger-Gateau
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

View more
  50 in total

1.  Interferon-γ as a Potential Link between Diabetes Mellitus and Dementia.

Authors:  Danielle Cozachenco; Maria C Selles; Felipe C Ribeiro
Journal:  J Neurosci       Date:  2019-06-12       Impact factor: 6.167

2.  Exendin-4 Reverses Biochemical and Functional Alterations in the Blood-Brain and Blood-CSF Barriers in Diabetic Rats.

Authors:  Caroline Zanotto; Fabrício Simão; Manuela Sangalli Gasparin; Regina Biasibetti; Lucas Silva Tortorelli; Patrícia Nardin; Carlos-Alberto Gonçalves
Journal:  Mol Neurobiol       Date:  2016-03-01       Impact factor: 5.590

3.  Sex-specific relationship of cardiometabolic syndrome with lower cortical thickness.

Authors:  Si Eun Kim; Jin San Lee; Sookyoung Woo; Seonwoo Kim; Hee Jin Kim; Seongbeom Park; Byung In Lee; Jinse Park; Yeshin Kim; Hyemin Jang; Seung Joo Kim; Soo Hyun Cho; Byungju Lee; Samuel N Lockhart; Duk L Na; Sang Won Seo
Journal:  Neurology       Date:  2019-08-23       Impact factor: 9.910

Review 4.  Strategies for dementia prevention: latest evidence and implications.

Authors:  Gopalkumar Rakesh; Steven T Szabo; George S Alexopoulos; Anthony S Zannas
Journal:  Ther Adv Chronic Dis       Date:  2017-06-27       Impact factor: 5.091

Review 5.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

Review 6.  The rise and fall of insulin signaling in Alzheimer's disease.

Authors:  B Chami; A J Steel; S M De La Monte; Greg T Sutherland
Journal:  Metab Brain Dis       Date:  2016-02-16       Impact factor: 3.584

Review 7.  The diabetic brain and cognition.

Authors:  Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

8.  Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells.

Authors:  Koji Hayakawa; Yasuharu Sakamoto; Osamu Kanie; Atsuko Ohtake; Shusaku Daikoku; Yukishige Ito; Kunio Shiota
Journal:  Epigenetics       Date:  2017-11-24       Impact factor: 4.528

9.  Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics.

Authors:  Andisheh Abedini; Annette Plesner; Ping Cao; Zachary Ridgway; Jinghua Zhang; Ling-Hsien Tu; Chris T Middleton; Brian Chao; Daniel J Sartori; Fanling Meng; Hui Wang; Amy G Wong; Martin T Zanni; C Bruce Verchere; Daniel P Raleigh; Ann Marie Schmidt
Journal:  Elife       Date:  2016-05-23       Impact factor: 8.140

10.  Yours, Mine, and Ours: A Qualitative Analysis of the Impact of Type 1 Diabetes Management in Older Adult Married Couples.

Authors:  Michelle L Litchman; Sarah E Wawrzynski; Nancy A Allen; Eunjin L Tracy; Caitlin S Kelly; Vicki S Helgeson; Cynthia A Berg
Journal:  Diabetes Spectr       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.